KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Return on Assets: 2019-2025

Historic Return on Assets for Castle Biosciences (CSTL) over the last 6 years, with Sep 2025 value amounting to -0.02%.

  • Castle Biosciences' Return on Assets fell 3.00% to -0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.02%, marking a year-over-year decrease of 3.00%. This contributed to the annual value of 0.04% for FY2024, which is 16.00% up from last year.
  • Per Castle Biosciences' latest filing, its Return on Assets stood at -0.02% for Q3 2025, which was down 22.23% from -0.02% recorded in Q2 2025.
  • Castle Biosciences' 5-year Return on Assets high stood at 0.03% for Q4 2024, and its period low was -0.21% during Q2 2023.
  • For the 3-year period, Castle Biosciences' Return on Assets averaged around -0.07%, with its median value being -0.02% (2025).
  • Per our database at Business Quant, Castle Biosciences' Return on Assets fell by 11bps in 2023 and then grew by 20bps in 2024.
  • Castle Biosciences' Return on Assets (Quarterly) stood at -0.07% in 2021, then decreased by 8bps to -0.15% in 2022, then climbed by 2bps to -0.13% in 2023, then increased by 16bps to 0.03% in 2024, then decreased by 3bps to -0.02% in 2025.
  • Its Return on Assets stands at -0.02% for Q3 2025, versus -0.02% for Q2 2025 and -0.01% for Q1 2025.